ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL.

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). They believe that Arbutus' comprehensive HBV pipeline of drugs and drug candidates optimally positions us to transform the HBV treatment landscape and to capitalize on the HBV global market opportunity. They are developing a portfolio of drug candidates with multiple mechanisms of action that They believe will result in a combination therapy to cure HBV. Specifically, They seek to effect a cure by targeting the three pillars necessary to develop a curative regimen for HBV. This includes suppressing HBV replication within liver cells, stimulating and reactivating the body’s immune system so that it can mount an effective defense against the virus and eliminating the reservoir of viral genomic material known as covalently closed circular DNA, or cccDNA, that is the source of HBV persistence.

Part of Horizon Therapeutics Plc, Horizon Pharma Rheumatology LLC is an American company that manufactures pharmaceuticals.

AZTherapies is an advanced clinical-stage biopharmaceutical company developing novel therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population. Advancing a growing pipeline to treat patients with few therapeutic options, the Company’s lead candidate, ALZT-OP1, is built on a multi-modal approach that recognizes neuroinflammation as a root cause of serious neurodegeneration and seeks to stop or slow the progression of the disease. The Phase 3 COGNITE trial in early Alzheimer’s disease is fully enrolled and expected to complete in late 2020. Following the lead program, AZTherapies is advancing candidates for the treatment of post-ischemic stroke cognitive impairment, amyotrophic lateral sclerosis (ALS), and other indications. AZTherapies is a private company founded in 2011 and headquartered in Boston, Massachusetts.

Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China.

Guangxi Yuyuan Pharmaceutical Co., Ltd. engages in the production and sale of large-volume infusions. Its products include multi-layer co-extruded film infusion bags, polypropylene infusion bottles, polypropylene combination covers for easy-fold plastic infusion containers, and upright polypropylene infusion bags. The company was on March 18, 1997 and is headquartered in Qinzhou, China.

Yawlih Technology (Beijing) Co. Ltd. (doing business as Lead Medical) is a Chinese company located in Beijing. The firm develops platform application software modules for data processing needs of medical industry. It was founded in 2015 by Xiao Han and Shang Yang.\nThe company says this about itself: Lead Medical, formerly known as Yawlih Technology, founded in July 2015 is a provider of data service and advanced analytics to healthcare professionals in China. Lead Medical serves public hospitals in China with the goal of minimizing redundant manual input and errors in daily hospital workflow. The company's data warehouse is built upon natural language processing and machine learning technologies and tailored specifically for Chinese hospitals while being compatible with international standards. Currently, the company is the go-to partner for local hospitals in the era of data driven decisions, management, and innovation.

Guangzhou Langsheng Pharmaceutical Co. Ltd. is a Chinese company. The firm manufactures and markets vinyl windows.

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

Jiaozuo Zhuoli Membrane Materials Co., Ltd., established on 2019-09-19, Business scope includes production,Sales:thermal print ribbon,Sublimation film,ink wheel,Ribbon,Film Hot Stamping,transfer printing,printing material,Labels and printed materials,Printing machinery and accessories,Food packaging and coding machinery;Encoding software,Research and development of related technologies for electronic connection materials and hot stamping materials,transfer,Serve;Sales:Chemical raw materials(Does not contain flammable, explosive and toxic and harmful chemicals);Import and export of goods or technology**Involved in licensing projects,It should be operated after obtaining the permission of the relevant department

Changshu Jingliangwei Medical Device Technology Co., Ltd., established on 2012-09-18, Business scope includes general items:Wholesale of Class II Medical Devices;Wholesale of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Wholesale of hardware products;Plastic Products Wholesale;Manufacturing of daily necessities;Wholesale of machinery and equipment;Stationery Wholesale;stationery manufacturing;Intellectual Property Services;Technology guidance;Advertising Design,make,acting;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Retailing of computer software, hardware and auxiliary equipment;AI Hardware Sales;Household Appliances Wholesale;Retailing of Maternal and Baby Products;Wholesale of kitchenware, sanitary ware and daily sundries;Wholesale hygiene products;Personal Hygiene Retail;Sales of hygiene products and single-use medical products;Household Appliances Retail;General merchandise wholesale;culture,Manufacturing of office equipment;Office Equipment Wholesale;Wholesale of sporting goods and equipment;Manufacturing of plastic products;Manufacturing of wearable smart devices;Production of Class I Medical Devices;daily mask(non-medical)Production;daily mask(non-medical)Sales;Sales of labor protection products;Wholesale medical masks;Retailing of protective equipment for healthcare workers(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.